BACKGROUND
There are more than 150,000 lower extremity amputations in the U.S. each year, most due to circulation problems.
Angioplasty below the knee can be limb-saving for patients at risk of amputation due to poor circulation.
THE PROBLEM
But angioplasty procedures below the knee are complex, and typically require numerous exchanges of specialized equipment during a procedure.
They also use x-ray contrast, which can damage kidney function.
THE SOLUTION
A multifunctional catheter that serves as a crossing catheter, diagnostic angiography catheter, and angioplasty balloon catheter can reduce equipment and contrast needs and streamline below knee angioplasty procedures.
READ MOREFinesse InjectableTM Angioplasty Balloon Catheter
The Summa Finesse InjectableTM angioplasty balloon catheter is a line of novel multifunctional angioplasty balloon catheters developed to streamline complex below-knee interventions, reduce equipment use, and reduce contrast and radiation.
New Product Category
Finesse is the only .014″-compatible catheter that enables lesion traversal, diagnostic angiography, and angioplasty with the same device. It’s not just an angioplasty balloon catheter; it’s a revascularization multitool that functions as a crossing catheter, diagnostic catheter, and angioplasty balloon catheter.
learn more
Ergonomic Design
Ergonomic design in medical devices is crucial for enhancing user experience, reducing strain, and improving safety.
Finesse is designed to make complex revascularization procedures easier for the operator to perform.
Ultra-low Contrast Angioplasty
Contrast-sparing angioplasty is the essential for many patients with chronic kidney disease, who are at risk of contrast-induced kidney toxicity. Ultra-low dose contrast is enabled by injection of contrast close to the site being imaged. The image above was obtained with just 1 ml equivalent of contrast (300 mg/ml).
learn moreKey Opinion Leader Testimonials
Here’s what clinical thought leaders say about Finesse:
“Limb salvage angioplasty procedures are complex. Reducing catheter exchanges is essential”
Rob Lookstein, M.D.
“In our busy CLI practice, this will definitely be an important tool for us”
John Rundback, M.D.
“Contrast appears distally almost immediately–we’re using less contrast and less radiation’”
Kevin Herman, M.D.
Latest News
Check back for exciting news!!
FDA Clears Finesse Injectable “Gen 2”
Expanded Multifunctional Angioplasty Catheter Product Line for BTK Procedures CAMBRIDGE, Massachusetts, July 17, 2024— Summa Therapeutics, a specialty angioplasty balloon medical device company, announced today that “Gen 2” of Summa’s[…]
Read more
